Related Experiment Videos
Birth defects and epilepsy medication.
1University Hospitals Coventry and Warwickshire NHS Trust, Neusosciences Department, Clifford Bridge Road, Coventry, CV2 2DX, UK. n.adab@virgin.net
Expert Review of Neurotherapeutics
|June 21, 2006
Summary
Epilepsy in pregnancy affects 1 in 200 pregnancies. Antiepileptic drugs may increase risks for major malformations and cognitive issues in children exposed in utero.
Area of Science:
- Neurology
- Obstetrics
- Teratology
Background:
- Epilepsy is a common neurological disorder affecting approximately 1 in 200 pregnancies.
- Many women with epilepsy require antiepileptic drug (AED) treatment during pregnancy.
Purpose of the Study:
- To review the evidence on risks associated with in utero exposure to AEDs.
- To discuss implications for counseling and treatment of pregnant women with epilepsy.
Main Methods:
- Literature review of existing studies on AEDs and pregnancy outcomes.
- Synthesis of evidence regarding major malformations and cognitive development.
Main Results:
- Growing evidence suggests an increased risk of major malformations in children exposed to AEDs in utero.
- Potential for later cognitive problems in children exposed to AEDs during pregnancy.
Conclusions:
- Pregnant women with epilepsy and their healthcare providers must weigh AED risks and benefits carefully.
- Informed counseling and individualized treatment plans are crucial for managing epilepsy during pregnancy.